Click on the links to access the following information:
Ovarian Cancer and OVA1: ROUNDS interviews Frederick R. Ueland, J. Craig Strafford, MD, MPH, ACOG District V Newsletter, July 2011
Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors, Fredrick R. Ueland, Obstetrics & Gynecology, June 2011
Performance of the American College of Obstetricians and Gynecologists' Ovarian Tumor Referral Guidelines With a Multivariate Index Assay, Rachel Ware Miller, MD, Obstetrics & Gynecology, June 2011
The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer, ACOG/SGO Committee Opinion, March 2011
OVA1: A New Tool For Evaluating Ovarian Masses, J. Craig Strafford, MD, MPH, ACOG District V Newsletter, March 2011
OVA1 Identifies Early Stage Ovarian Cancer with High Sensitivity, Frederick R. Ueland, MD, IGCS Annual Meeting Poster & Presentation Abstract, October 2010
A Multi-Institutional Evaluation of ACOG and SGO Referral Guidelines For an Ovarian Mass, Rachel Ware, MD, SGO Annual Meeting Presentation Abstract, March 2010
The OVA1 Test Improves The Preoperative Assessment of Ovarian Tumors, Frederick R. Ueland, MD, SGO Annual Meeting Presentation Abstract, March 2010
FDA Clears Test For Ovarian Cancer; Test Can Help Identify Malignancies, Guide Surgical Decisions, FDA Press Release, Sept 11, 2009
Society of Gynecologic Oncologists Statement on OVA1, Sept 2009
AACR Annual Meeting, April 2010 Presentation Abstract: OVA1: An In Vitro Diagnostic Multivariate Index Assay for Preoperative Assessment of Ovarian Tumors, Zhen Zhang, PhD: AACR Annual Meeting Presentation Abstract, April 2010
OVA1 Test For Preoperative Assessment of Ovarian Cancer, Jame Abraham, MD, Community Oncology, June 2010
Replacing CA-125 with OVA1 Correctly Identifies Over 70% of Malignancies Missed by ACOG Criteria, Frederick R. Ueland, MD, Community Oncology, June 2010
